GL1X · GenesisL1 explorer

MolNFT v1 · #67577 · protein

Crystal structure of cpha N220G mutant with inhibitor 18

3IOG · Beta-lactamase: “Crystal structure of cpha N220G mutant with inhibitor 18”. X-ray diffraction, 3 ligands (SDF, ZN, SO4), 1 pocket (best druggability 0.55). MolNFT v1 #67577 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
3IOG
Type
protein
Length
227 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
P26918
Ligands
SDF, ZN, SO4
Pockets
1 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein22730% helix, 25% strandP26918

Ligands and binding sites

  • SDF · [(R)-(2,4-dichlorophenyl)(sulfanyl)methyl]phosphonic acid · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • SO4 · Sulfate ion · ion · 5 copies · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11780.550.8021SDF

Compared structures

  • 3IOG · Crystal structure of CphA N220G mutant with inhibitor 18 · the same entry in another collection · chain A against A, TM-score 1.00
  • P26918 · AlphaFold monomer V2.0 prediction for metallo-beta-lactamase type 2 (P26918) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.